Highlights BioMarin Pharmaceutical Inc.

Equities

BMRN

US09061G1013

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 02:30:00 19/02/2026 am IST			5-day change	1st Jan Change
61.83 ^USD	+3.14%		+2.52%	+4.04%

18/02	Tarsus Pharmaceuticals, Inc. Appoints David E. I. Pyott to Its Board of Directors and Chairperson of Commercial Committee and as Member of Nominating Committee and Compensation Committee of the Board, Effective on February 18, 2026	CI
13/02	BioMarin Pharmaceutical Inc. Announces Closing of Private Offering of Senior Notes	CI

Highlights

13/02	BioMarin Pharmaceutical Inc. Announces Closing of Private Offering of Senior Notes	CI
13/02	BridgeBio's oral drug improves growth in children with dwarfism in late-stage study	RE
12/02	BridgeBio's oral drug boosts growth in children with dwarfism in late-stage trial	RE
11/02	BioMarin Receives Health Canada Notice of Compliance with Conditions for Vosoritide, for Achondroplasia	CI
26/01	Sector Update: Health Care Stocks Mixed Premarket Monday	MT
26/01	Biomarin Pharmaceutical Inc. Announces $850 Million of Senior Unsecured Notes Due 2034	CI
26/01	BioMarin Pharmaceutical Plans $850 Million Notes Offering, Lines Up $2 Billion Syndicated Loan	MT
21/01	When America Starts to Feel Like a Risky Asset
20/01	Greenland, Tariffs, and the Quiet Revolt of the Bond Market
14/01	BioMarin Pharmaceuticals Aims for Sustained Growth in 2026, Wedbush Says	MT
13/01	BioMarin Pharmaceutical Reports Preliminary 2025 Revenue, Details Asset Write-Down	MT
13/01	Biomarin Pharmaceutical Inc estimates $3.2 billion in total revenues for FY - SEC filing	RE
08/01	Veeva Systems, BioMarin Pharmaceutical Enter Long-Term Partnership	MT
22/12	BioMarin Pharmaceutical Inc. Announces its Decision to Discontinue Development of BMN349	CI
20/12	Health Care Up Amid Deal Activity -- Health Care Roundup	DJ
20/12	Sector Update: Health Care Stocks Rise Late Afternoon	MT
20/12	Sector Update: Health Care Stocks Higher Friday Afternoon	MT
19/12	Sector Update: Health Care	MT
19/12	Top Midday Gainers	MT
19/12	Top Midday Stories: Oracle, Others Form JV to Oversee TikTok in US; More Drugmakers to Announce US Drug Price Deals	MT
19/12	BioMarin Pharmaceutical Inc. submitted a non-binding indication of interest to acquire Amicus Therapeutics, Inc. from The Vanguard Group, Inc., Wellington Management Group LLP, BlackRock, Inc., William Blair Investment Management, LLC, and others for $4.7 billion.	CI
19/12	BioMarin Pharmaceutical to Acquire Amicus Therapeutics in $4.8 Billion Deal	MT
19/12	BioMarin Pharmaceutical to Acquire Amicus Therapeutics for $4.8 Billion; Shares Jump	MT
19/12	Amicus to pay Biomarin Pharmaceutical $175 million merger termination fee	RE
19/12	Sector Update: Health Care Stocks Mixed Premarket Friday	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Highlights BioMarin Pharmaceutical Inc.

Equities

BMRN

US09061G1013

Pharmaceuticals

Highlights

Filters